However, derangements in adrenergic–adipokine signaling in a case of a deficiency of irisin production may be more valuable for adverse cardiac remodeling and cardiovascular outcomes among T2DM patients [64,65,66]. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.